| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
103,474 |
94,333 |
$16.27M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
100,598 |
92,805 |
$13.50M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
78,445 |
71,047 |
$4.54M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
16,999 |
15,246 |
$3.93M |
| 80053 |
Comprehensive metabolic panel |
146,542 |
129,960 |
$3.54M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
50,376 |
46,058 |
$3.39M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
58,449 |
53,626 |
$2.98M |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
46,574 |
17,674 |
$1.81M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
13,617 |
12,780 |
$1.31M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
12,501 |
11,311 |
$1.27M |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
2,791 |
1,417 |
$1.15M |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
28,515 |
26,906 |
$1.08M |
| 71046 |
Radiologic examination, chest; 2 views |
32,861 |
29,807 |
$1.01M |
| 99223 |
Prolong inpt eval add15 m |
6,825 |
5,973 |
$793K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
28,072 |
25,342 |
$691K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
5,204 |
4,815 |
$614K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
7,810 |
6,974 |
$556K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
9,089 |
8,123 |
$481K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
843 |
658 |
$384K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
4,079 |
3,481 |
$368K |
| 95811 |
|
1,088 |
826 |
$366K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,609 |
1,502 |
$309K |
| 0002A |
|
12,826 |
10,512 |
$292K |
| 0001A |
|
14,026 |
11,438 |
$291K |
| 64615 |
|
1,951 |
1,071 |
$261K |
| 87631 |
|
12,119 |
11,462 |
$247K |
| 99233 |
Prolong inpt eval add15 m |
4,929 |
2,133 |
$246K |
| G0399 |
Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation |
1,988 |
1,487 |
$183K |
| 99215 |
Prolong outpt/office vis |
2,226 |
1,992 |
$176K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
4,349 |
2,414 |
$166K |
| 97803 |
|
3,532 |
3,085 |
$148K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
5,939 |
5,735 |
$136K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
153,733 |
135,684 |
$135K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
911 |
880 |
$133K |
| 93970 |
|
5,128 |
4,599 |
$132K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
5,310 |
4,709 |
$120K |
| 01967 |
Neuraxial labor analgesia/anesthesia for planned vaginal delivery |
129 |
124 |
$119K |
| 99222 |
Initial hospital care, per day, moderate complexity |
1,300 |
1,208 |
$115K |
| 36415 |
Collection of venous blood by venipuncture |
80,414 |
72,023 |
$105K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
4,934 |
1,353 |
$99K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
1,941 |
1,715 |
$87K |
| 99460 |
|
896 |
878 |
$85K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
19,198 |
15,649 |
$81K |
| 93971 |
|
5,573 |
5,184 |
$78K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,795 |
2,476 |
$73K |
| 95910 |
|
456 |
250 |
$73K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,478 |
961 |
$73K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
698 |
616 |
$70K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
961 |
472 |
$64K |
| 81420 |
Fetal chromosomal aneuploidy genomic sequence analysis panel |
103 |
102 |
$59K |
| 81001 |
|
60,480 |
55,208 |
$59K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
879 |
798 |
$56K |
| 95819 |
|
647 |
501 |
$51K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
847 |
812 |
$51K |
| 95886 |
|
1,409 |
753 |
$38K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,483 |
1,419 |
$37K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,483 |
1,419 |
$37K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
335 |
279 |
$37K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
309 |
278 |
$37K |
| 90834 |
Psychotherapy, 45 minutes with patient |
524 |
342 |
$36K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,044 |
568 |
$35K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
295 |
292 |
$34K |
| 59025 |
Fetal non-stress test |
699 |
328 |
$32K |
| 80061 |
Lipid panel |
3,765 |
3,525 |
$31K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
12,175 |
11,198 |
$31K |
| 99464 |
|
441 |
430 |
$31K |
| 99479 |
Subsequent intensive care, per day, very low birth weight infant |
256 |
66 |
$30K |
| 90686 |
|
1,403 |
1,364 |
$26K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,552 |
2,370 |
$25K |
| 86780 |
|
2,490 |
2,357 |
$25K |
| 90791 |
Psychiatric diagnostic evaluation |
217 |
204 |
$25K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
72 |
37 |
$23K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
632 |
461 |
$23K |
| 86140 |
|
7,532 |
4,113 |
$22K |
| 99480 |
Subsequent intensive care, per day, low birth weight infant |
200 |
52 |
$22K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,555 |
3,328 |
$22K |
| 87536 |
|
419 |
388 |
$22K |
| 99219 |
|
293 |
230 |
$21K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,076 |
1,039 |
$19K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
1,647 |
1,558 |
$18K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,263 |
1,112 |
$16K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
852 |
809 |
$16K |
| 0012A |
|
671 |
524 |
$16K |
| 73630 |
|
519 |
360 |
$16K |
| 76813 |
|
146 |
141 |
$15K |
| 71045 |
Radiologic examination, chest; single view |
279 |
259 |
$15K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
336 |
327 |
$15K |
| 86900 |
|
190 |
174 |
$14K |
| 99469 |
Subsequent inpatient neonatal critical care, per day, 28 days or younger |
46 |
12 |
$14K |
| 0011A |
|
706 |
554 |
$13K |
| 87660 |
|
900 |
863 |
$13K |
| 87510 |
|
900 |
863 |
$13K |
| 87480 |
|
900 |
863 |
$13K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
94 |
92 |
$12K |
| 85652 |
|
7,354 |
4,012 |
$11K |
| 49083 |
|
14 |
12 |
$11K |
| 83970 |
|
535 |
497 |
$11K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
60,606 |
51,339 |
$11K |
| 99205 |
Prolong outpt/office vis |
85 |
78 |
$10K |
| 0004A |
|
402 |
367 |
$10K |
| 73610 |
|
284 |
258 |
$10K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
114 |
108 |
$10K |
| 93000 |
|
913 |
858 |
$10K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
808 |
790 |
$9K |
| 93922 |
|
1,030 |
862 |
$8K |
| 84425 |
|
578 |
552 |
$8K |
| 86803 |
|
677 |
652 |
$8K |
| 99220 |
|
79 |
66 |
$8K |
| 82607 |
|
797 |
757 |
$8K |
| 82746 |
|
782 |
747 |
$7K |
| 73110 |
|
221 |
197 |
$7K |
| 99462 |
|
170 |
159 |
$7K |
| 87070 |
|
1,194 |
1,148 |
$7K |
| 86480 |
|
135 |
132 |
$7K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
56 |
56 |
$6K |
| 99442 |
|
581 |
414 |
$6K |
| 82550 |
|
7,941 |
6,135 |
$6K |
| 20611 |
|
96 |
84 |
$5K |
| 77014 |
|
140 |
53 |
$5K |
| 87634 |
|
127 |
120 |
$5K |
| 95908 |
|
42 |
25 |
$5K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
40,868 |
36,497 |
$5K |
| 0031A |
|
188 |
172 |
$5K |
| 0064A |
|
174 |
165 |
$5K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
27 |
25 |
$5K |
| 86359 |
|
208 |
197 |
$5K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
372 |
348 |
$5K |
| 84466 |
|
555 |
527 |
$5K |
| 99459 |
|
279 |
275 |
$4K |
| 82728 |
|
495 |
470 |
$4K |
| 81003 |
|
2,881 |
2,687 |
$4K |
| 76820 |
|
94 |
48 |
$4K |
| 0071A |
|
110 |
110 |
$4K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
128 |
120 |
$4K |
| 96160 |
|
1,173 |
1,088 |
$4K |
| 90670 |
|
185 |
176 |
$4K |
| 90656 |
|
174 |
173 |
$4K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
254 |
232 |
$4K |
| 59514 |
|
12 |
12 |
$3K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
26 |
26 |
$3K |
| 86361 |
|
191 |
184 |
$3K |
| 73600 |
|
127 |
80 |
$3K |
| 83880 |
|
161 |
149 |
$3K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
697 |
574 |
$3K |
| 90698 |
|
155 |
146 |
$3K |
| 80069 |
|
871 |
758 |
$3K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
12 |
12 |
$3K |
| 84703 |
|
6,297 |
6,000 |
$3K |
| 99443 |
|
129 |
109 |
$3K |
| 0240U |
|
28 |
28 |
$3K |
| 0072A |
|
74 |
74 |
$3K |
| 84481 |
|
284 |
265 |
$3K |
| 83690 |
|
14,302 |
13,145 |
$3K |
| 77336 |
|
25 |
12 |
$3K |
| 99217 |
|
64 |
53 |
$3K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
211 |
196 |
$3K |
| 84484 |
|
18,513 |
14,009 |
$2K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
14 |
12 |
$2K |
| 90682 |
|
45 |
43 |
$2K |
| 84439 |
|
445 |
401 |
$2K |
| 83540 |
|
555 |
527 |
$2K |
| 93880 |
|
70 |
55 |
$2K |
| 94760 |
|
1,196 |
1,126 |
$2K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
26 |
25 |
$2K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
13 |
13 |
$2K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
13 |
13 |
$2K |
| 82570 |
|
692 |
596 |
$2K |
| 99221 |
|
21 |
21 |
$2K |
| 87653 |
|
65 |
64 |
$2K |
| 90677 |
|
83 |
78 |
$2K |
| 90648 |
|
79 |
75 |
$2K |
| 99173 |
|
519 |
514 |
$1K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
15 |
13 |
$1K |
| 86360 |
|
46 |
41 |
$1K |
| 96161 |
|
474 |
407 |
$1K |
| 84702 |
|
380 |
359 |
$1K |
| 87522 |
Neg quan hep c or qual rna |
59 |
51 |
$1K |
| 99463 |
|
12 |
12 |
$1K |
| 93990 |
|
76 |
52 |
$1K |
| 98968 |
|
33 |
31 |
$1K |
| 97165 |
|
14 |
13 |
$1K |
| 90723 |
|
54 |
52 |
$1K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
13 |
12 |
$1K |
| 87340 |
|
254 |
236 |
$1K |
| 80202 |
|
112 |
39 |
$1K |
| 90715 |
|
47 |
44 |
$1K |
| 87077 |
|
174 |
164 |
$919.76 |
| 73130 |
|
29 |
26 |
$917.47 |
| 84156 |
|
529 |
486 |
$891.51 |
| 83718 |
|
147 |
129 |
$868.03 |
| 99356 |
|
43 |
13 |
$848.63 |
| 96127 |
|
123 |
120 |
$789.29 |
| 85027 |
|
245 |
232 |
$776.19 |
| 99225 |
|
18 |
13 |
$751.47 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
26 |
26 |
$727.96 |
| 86317 |
|
65 |
65 |
$618.47 |
| 84478 |
|
147 |
129 |
$613.55 |
| 83605 |
|
4,285 |
3,596 |
$594.32 |
| 87186 |
|
83 |
77 |
$588.98 |
| 0124A |
|
29 |
27 |
$581.24 |
| 20610 |
|
15 |
12 |
$560.01 |
| 90744 |
|
27 |
27 |
$548.92 |
| 87081 |
|
166 |
159 |
$544.70 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
150 |
140 |
$514.29 |
| 94060 |
|
88 |
79 |
$504.54 |
| 11045 |
|
33 |
14 |
$500.72 |
| 84630 |
|
70 |
67 |
$497.87 |
| 86787 |
|
58 |
58 |
$470.46 |
| 85014 |
|
341 |
320 |
$460.52 |
| 85610 |
|
1,259 |
1,084 |
$437.52 |
| 86704 |
|
50 |
50 |
$435.01 |
| 84590 |
|
57 |
55 |
$429.81 |
| 99406 |
|
40 |
39 |
$417.35 |
| 0054A |
|
14 |
12 |
$414.40 |
| 0003A |
|
30 |
25 |
$408.00 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
43 |
41 |
$399.30 |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
169 |
117 |
$388.90 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,615 |
4,320 |
$388.77 |
| 99417 |
Prolong home eval add 15m |
12 |
12 |
$372.60 |
| 86694 |
|
18 |
18 |
$371.67 |
| 86850 |
|
255 |
227 |
$365.17 |
| 81025 |
|
65 |
63 |
$355.22 |
| 93244 |
|
18 |
17 |
$354.26 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
14 |
14 |
$354.14 |
| 93018 |
|
27 |
26 |
$350.38 |
| 82784 |
|
53 |
39 |
$320.08 |
| 90633 |
|
14 |
14 |
$292.04 |
| 0134A |
|
14 |
14 |
$257.60 |
| 99441 |
|
26 |
14 |
$252.96 |
| 90713 |
|
15 |
14 |
$244.16 |
| 86364 |
|
26 |
24 |
$213.05 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
27 |
26 |
$186.62 |
| 84460 |
|
64 |
62 |
$186.38 |
| 90710 |
|
14 |
14 |
$185.32 |
| 84450 |
|
64 |
62 |
$182.07 |
| 83993 |
|
13 |
12 |
$176.50 |
| 82043 |
|
49 |
46 |
$166.57 |
| 83516 |
|
24 |
13 |
$165.43 |
| 82951 |
|
15 |
15 |
$165.31 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
95 |
84 |
$161.05 |
| 95874 |
|
59 |
24 |
$157.81 |
| 86334 |
|
17 |
15 |
$147.86 |
| 82947 |
|
40 |
40 |
$146.17 |
| 85730 |
|
85 |
78 |
$145.33 |
| 82248 |
|
30 |
28 |
$144.80 |
| 87205 |
|
40 |
38 |
$142.51 |
| 85018 |
|
153 |
137 |
$133.42 |
| 84163 |
|
13 |
12 |
$123.70 |
| 83883 |
|
28 |
14 |
$120.46 |
| 83655 |
|
12 |
12 |
$113.20 |
| 86762 |
|
117 |
102 |
$112.67 |
| 92552 |
|
33 |
30 |
$107.44 |
| 96150 |
|
13 |
12 |
$104.40 |
| 87071 |
|
31 |
28 |
$103.32 |
| 84550 |
|
62 |
59 |
$95.86 |
| 82553 |
|
6,242 |
5,145 |
$94.98 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
13,027 |
11,780 |
$90.08 |
| 83735 |
|
1,353 |
1,217 |
$70.67 |
| 84165 |
|
15 |
15 |
$55.39 |
| 82950 |
|
12 |
12 |
$53.89 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
6,904 |
6,341 |
$51.84 |
| 86592 |
|
12 |
12 |
$42.40 |
| 84160 |
|
15 |
15 |
$26.71 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
149 |
140 |
$22.55 |
| 82803 |
|
433 |
390 |
$18.00 |
| 86901 |
|
178 |
162 |
$10.32 |
| J0689 |
Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg |
84 |
79 |
$5.03 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
13 |
13 |
$1.69 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
3,498 |
3,136 |
$0.89 |
| 85379 |
|
12 |
12 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
529 |
454 |
$0.00 |
| G0378 |
Hospital observation service, per hour |
376 |
273 |
$0.00 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
17 |
15 |
$0.00 |
| J3490 |
Unclassified drugs |
271 |
217 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
1,669 |
1,364 |
$0.00 |
| 84075 |
|
26 |
24 |
$0.00 |
| 96376 |
|
84 |
76 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
916 |
773 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
69 |
61 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
12 |
12 |
$0.00 |
| 99140 |
|
13 |
12 |
$0.00 |
| 86376 |
|
13 |
12 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
44 |
39 |
$0.00 |
| 82040 |
|
14 |
12 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
50 |
49 |
$0.00 |
| C2617 |
Stent, non-coronary, temporary, without delivery system |
12 |
12 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
13 |
12 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
15 |
12 |
$0.00 |
| C1769 |
Guide wire |
12 |
12 |
$0.00 |
| 84145 |
|
586 |
520 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,584 |
1,424 |
$0.00 |
| 99152 |
|
13 |
12 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
176 |
103 |
$0.00 |
| 87400 |
|
42 |
37 |
$0.00 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
16 |
13 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
69 |
65 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
34 |
31 |
$0.00 |
| 84155 |
|
26 |
24 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
14 |
13 |
$0.00 |
| 82247 |
|
26 |
24 |
$0.00 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
14 |
13 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
12 |
12 |
$0.00 |